Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Temporally-Modulated Pulsed Radiation Therapy after Prior External Beam Radiation Therapy for the Treatment of Recurrent IDH-Mutant Gliomas

Trial Status: closed to accrual and intervention

This clinical trial tests the safety and side effects of temporally-modulated pulsed radiation therapy (TMPRT) in treating patients with gliomas that have been treated with radiation therapy in the past, have come back (recurrent), and have a genetic change in the IDH gene (IDH-mutant). Standard radiation therapy is typically delivered once daily in a continuous manner, during which patients lie on a treatment table for approximately 10 minutes. TMPRT is a new way of delivering radiation therapy by breaking each daily treatment into 10 segments, or “pulses,” with about 3 minutes of rest in between each pulse of radiation. TMPRT may be more efficient at killing tumor cells while also reducing damage to normal brain tissue and blood vessels.